THROMBOSIS AND HEMOSTASIS Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs
نویسندگان
چکیده
1Pharmacology Department, Ablynx NV, Zwijnaarde, Belgium; 2Department of Interventional Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands; 3Department of Hematology and Cell Biology, University of Free State, Bloemfontein, South Africa; 4Department of Chemistry, Manufacturing and Controls, Ablynx NV, Zwijnaarde, Belgium; and 5Clinical Operations Department, Ablynx NV, Zwijnaarde, Belgium
منابع مشابه
The future of glycoprotein VI as an antithrombotic target.
The treatment of acute coronary syndromes has been considerably improved in recent years with the introduction of highly efficient antiplatelet drugs. However, there are still significant limitations: the recurrence of adverse vascular events remains a problem, and the improvement in efficacy is counterbalanced by an increased risk of bleeding, which is of particular importance in patients at r...
متن کاملAnimal Models of Thrombosis From Zebrafish to Nonhuman Primates: Use in the Elucidation of New Pathologic Pathways and the Development of Antithrombotic Drugs.
Thrombosis is a leading cause of morbidity and mortality worldwide. Animal models are used to understand the pathological pathways involved in thrombosis and to test the efficacy and safety of new antithrombotic drugs. In this review, we will first describe the central role a variety of animal models of thrombosis and hemostasis has played in the development of new antiplatelet and anticoagulan...
متن کاملNew antithrombotic drugs.
Thrombosis, both venous and arterial, is a major cause of morbidity and mortality worldwide. Consequently, there is an ongoing search for new antithrombotic drugs, particularly novel antiplatelet agents and anticoagulants. A better understanding of the biochemical pathways involved in platelet activation and coagulation and of the links between these systems and the impact of thrombosis on infl...
متن کاملTriple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting: Searching for the Best Combination.
Patients with atrial fibrillation (AF) who are treated with oral anticoagulants often have concurrent coronary artery disease. Triple oral antithrombotic therapy (TOAT) is often necessity to prevent stent thrombosis or myocardial infarction associated with percutaneous coronary intervention or acute coronary syndrome in patients with comorbid coronary artery disease and AF. Although the use of ...
متن کاملAnimal Models of Thrombosis From Zebrafish to Nonhuman Primates
Abstract: Thrombosis is a leading cause of morbidity and mortality worldwide. Animal models are used to understand the pathological pathways involved in thrombosis and to test the efficacy and safety of new antithrombotic drugs. In this review, we will first describe the central role a variety of animal models of thrombosis and hemostasis has played in the development of new antiplatelet and an...
متن کامل